26.02.2016 RHÖN-KLINIKUM AG  DE0007042301

DGAP-News: RHÖN-KLINIKUM AG: Provisional Figures for Financial Year 2015


 
DGAP-News: RHÖN-KLINIKUM AG / Key word(s): Preliminary Results/Preliminary Results RHÖN-KLINIKUM AG: Provisional Figures for Financial Year 2015 26.02.2016 / 07:00 The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- RHÖN-KLINIKUM AG Schlossplatz 1 D-97616 Bad Neustadt/Saale www.rhoen-klinikum-ag.com RHÖN-KLINIKUM AG: Provisional Figures for Financial Year 2015 - 765,109 patients treated - Financial figures affected by special influences - Revenues amount to Euro 1.11 billion - EBITDA stands at Euro 154.2 million - Net consolidated profit amounts to Euro 87.4 million - Outlook for 2016: revenues between Euro 1.17 billion and Euro 1.20 billion, EBITDA between Euro 155 million and Euro 165 million Bad Neustadt, 26th February 2016 The sale of a total of 43 hospitals which was completed in 2014 again affected RHÖN-KLINIKUM AG's figures in the past financial year, albeit to a considerably lesser extent. Positive and negative one-off effects continued to influence the corporate results during the entire financial year 2015,their size was a low two-digit million figure and they partially cancelled each other out. A total of 765,109 patients were treated at the five medical sites of our corporate group. Corporate revenues stood at Euro 1.11 billion with earnings before interest, taxes, depreciation and amortisation (EBITDA) amounting to Euro 154.2 million and net consolidated profit was at Euro 87.4 million. "2015 was our first full financial year after the strategic re-orientation. Particular focus was placed on further medical innovations and improving nursing care. Our strategy continues to offer very good prospects for growth. With our unique campus concept the company is well-equipped for the future - particularly with respect to improving and modernising in-patient/out-patient healthcare in rural areas," said Dr. Martin Siebert,CEO of RHÖN-KLINIKUM AG. "Following the second share repurchase scheme in 2015 we now have a very robust and solid financial basis for our future development," said CFO Jens-Peter Neumann. "We are financially strong enough to achieve operative growth, to make investments in medical innovations and to take advantage of any acquisition opportunities - should they be suitable. Particularly in unsettling times our company continues to be an attractive investment opportunity in the capital market." Outlook The company expects revenues of Euro 1.17 billion to Euro 1.20 billion and earnings before interest, taxes, depreciation and amortisation (EBITDA) of between Euro 155 million and Euro 165 million for the current financial year 2016. Positive and negative one-off effects will continue to influence the corporate results during the current financial year as well, their size is a low to medium two-digit million figure and they will partially cancel each other out. They generally stem from handling the transaction with Fresenius/Helios, the first consolidation and integration of the municipal hospital in Bad Neustadt, special budgets for innovation and e-health,outstanding accounting issues and setting up a larger out-patient centre at the university hospital in Marburg. Provisional, uncertified financial figures with possible rounding-off differences ************************************************************************** RHÖN‐KLINIKUM AG is one of the largest healthcare providers in Germany. At five medical sites with a total of 5,300 beds we offer cutting-edge medical care with a direct link to universities and research institutes. Our top five key areas of treatment are cardiological and coronary disease, neurological disorders, oncology, lung diseases as well as orthopedic and accident surgery. A total of over 15,000 employees work for RHÖN-KLINIKUM AG. Our facilities are located in Bad Berka, Bad Neustadt/Saale, Frankfurt (Oder) and Giessen and Marburg. Further information is available at: www.rhoen-klinikum-ag.com Your Contact Persons: RHÖN-KLINIKUM AG Achim Struchholz Head of Corporate Communication Schlossplatz 1 97616 Bad Neustadt/Saale T. + 49 - 9771 65-1327 F. + 49 - 9771 65-1820 [email protected] Dr. Kai G. Klinger Head of Investor Relations & Group Financing Schlossplatz 1 97616 Bad Neustadt/Saale T. + 49 - 9771 65-1318 F. + 49 - 9771 99-1736 [email protected] --------------------------------------------------------------------------- 26.02.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: RHÖN-KLINIKUM AG Salzburger Leite 1 97616 Bad Neustadt a.d.Saale Germany Phone: +49 (0)9771 - 65-0 Fax: +49 (0)9771 - 97 467 E-mail: [email protected] Internet: www.rhoen-klinikum-ag.com ISIN: DE0007042301 WKN: 704230 Indices: MDAX Listed: Regulated Market in Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Stuttgart; Terminbörse EUREX End of News DGAP News Service --------------------------------------------------------------------------- 440509 26.02.2016


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 1.211,08 1.232,91 1.303,90 1.360,16 1.402,01 1.446,09 1.510,00
EBITDA1,2 97,82 125,54 125,33 80,23 101,16 105,65 107,50
EBITDA-Marge3 8,08 10,18 9,61 5,90 7,22 7,31
EBIT1,4 38,70 64,94 56,80 10,60 30,52 36,11 41,00
EBIT-Marge5 3,20 5,27 4,36 0,78 2,18 2,50 2,72
Jahresüberschuss1 36,74 51,19 44,48 2,46 30,23 26,94 35,00
Netto-Marge6 3,03 4,15 3,41 0,18 2,16 1,86 2,32
Cashflow1,7 80,30 49,50 47,30 113,30 97,50 41,30 0,00
Ergebnis je Aktie8 0,53 0,73 0,65 0,02 0,42 0,38 0,51
Dividende8 0,22 0,29 0,00 0,00 0,00 0,15 0,35
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: KPMG

INVESTOR-INFORMATIONEN
©boersengefluester.de
Rhön-Klinikum
WKN Kurs in € Einschätzung Börsenwert in Mio. €
704230 11,000 Halten 736,59
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
15,28 27,78 0,54 18,97
KBV KCV KUV EV/EBITDA
0,60 17,84 0,51 7,66
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,15 0,15 1,36 05.06.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
08.05.2024 08.08.2024 09.11.2023 28.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
4,99% -2,46% 10,00% -12,35%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu RHÖN-KLINIKUM AG  ISIN: DE0007042301 können Sie bei EQS abrufen


Pflegeeinrichtungen , 704230 , RHK , XETR:RHK